NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Myoridge Co., Ltd.

Myoridge Co., Ltd.

Private
KyotoHealthcare & Life Scienceshttps://myoridge.co.jp/

Last Round

Strategic

Apr 25, 2022

Total Funding Raised

$5.9M

Momentum

Top 25%

of companies Caplight tracks

Company Overview

Myoridge Co., Ltd. is a biotechnology company that provides iPS cell-derived cardiomyocyte products and cell culture development services.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Precision Medicine, Advanced Materials, Smart Manufacturing

Business Model

B2B

Customer Profile

Services & Consulting, Hardware Sales

AI Layer

Application

Keywords

iPS cell-derived cardiomyocytesiPSCculture medium optimizationprotein-free mediaserum-free mediaCRO servicesregenerative medicinedrug discovery supportcell culture technologyxeno-free mediacell therapydisease modelingstem cell technologyAI media optimization

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Myoridge Co., Ltd. Comparables

Compare Myoridge Co., Ltd. with similar companies based on industry and business-model similarity.

Myoridge Co., Ltd. comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Axol Bioscience
82%
NEXEL Co., Ltd.
81%
Fujifilm Holdings Corporation
81%

Myoridge Co., Ltd. Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
StrategicApr 25, 2022
VC RoundMar 1, 2021
VC RoundJan 20, 2020
SeedApr 3, 2017

Key People

Founding team and executive leadership

Takeo Suzuki

CEO

Executive Team

Myoridge Co., Ltd. Investors

Notable investors and investment history

Myoridge Co., Ltd. investors
InvestorRounds
Beyond Next VenturesSeed
Kyoto University Innovation CapitalVC Round

Market signals

Structured signals derived from secondary market and firmographic data.

  • Apr 23, 2026

    Monthly visitors increased 31% MoM, reaching 3K.

  • Apr 25, 2022

    $4.76M raised from TOPPAN Holdings, Mitsubishi Chemical, and Sumitomo Chemical.

Myoridge Co., Ltd. Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Myoridge Co., Ltd. Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Myoridge Co., Ltd.'s valuation, stock price, and market status.

Firmographic Details

HeadquartersKyoto
Employee Range4
Year Founded2016
Last FundingApr 25, 2022

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.